Seeking Alpha

GlaxoSmithKline (GSK): Q4 core EPS of 32.6 pence beats by 1.3 pence; Revenues of £6.80B...

GlaxoSmithKline (GSK): Q4 core EPS of 32.6 pence beats by 1.3 pence; Revenues of £6.80B (-3% Y/Y) misses by £80M. Net profit -35% to £839M. Shares +0.2%. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|